ZYLOXTB(02190.HK): 2026 Interim Report - Profit Attributable to Shareholders stood at CNY 181.71 million, YoY increase of 49.93%

NewTimeSpace News: August 20, 2026, ZYLOXTB(02190.HK) released its Interim Report for the period ended December 31, 2026, Total Revenue stood at CNY 632.04 million, increased by 31.14% YoY; Net Profit stood at CNY 179.11 million, YoY increase of 47.78%; Profit Attributable to Shareholders stood at CNY 181.71 million, YoY increase of 49.93%; Basic Earnings Per Share (EPS) stood at CNY 0.57.

In terms of profitability, ZYLOXTB Gross Profit changed from CNY 343.11 million in the same period last year to CNY 463.89 million in the current period, increased by CNY 120.78 million; gross profit margin changed from 71.19% in the same period last year to 73.4% in the current period, increased by 2.21 percentage points; net profit changed from CNY 121.2 million in the same period last year to CNY 179.11 million in the current period, increased by CNY 57.91 million; net profit margin changed from 25.15% in the same period last year to 28.34% in the current period, increased by 3.19 percentage points. 

In terms of earnings quality, ZYLOXTB Operating Profit changed from CNY 94.08 million in the same period last year to CNY 187.44 million in the current period, increased by CNY 93.36 million; Operating Profit Margin changed from 19.52% in the same period last year to 29.66% in the current period, increased by 10.14 percentage points. 

In terms of financial soundness, ZYLOXTB Debt-to-Asset Ratio changed from 9.78% in the same period last year to 19.66% in the current period, increased by 9.88 percentage points; Total Equity changed from CNY 3.155 billion in the same period last year to CNY 2.999 billion in the current period, decreased by CNY 155.42 million; Current Liabilities changed from CNY 323.03 million in the same period last year to CNY 392.13 million in the current period, increased by CNY 69.1 million; Quick Ratio changed from 5.16 in the same period last year to 4.06 in the current period, decreased by 1.1 percentage points. 

In terms of R&D investment focus, ZYLOXTB R&D Expenses changed from CNY 121.6 million in the same period last year to CNY 106.37 million in the current period, decreased by CNY 15.23 million; R&D to Total Revenue Ratio changed from 25.23% in the same period last year to 16.83% in the current period, decreased by 8.4 percentage points. 

By the close of trading on August 20, 2026, ZYLOXTB(02190) saw a gain of 1.03% in its share price, closing at HKD 19.7. The full-day turnover stood at HKD 8.11 million, with the latest market capitalization at HKD 6.38 billion.

NewTimeSpace Disclaimer:All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.